Growing Market Presence Kamada is a global biopharmaceutical leader with 6 FDA-approved products sold across more than 30 countries, indicating a broad international footprint and opportunities for expanding distribution channels and partnerships.
Specialized Treatment Focus The company's focus on rare and serious conditions with limited treatment options presents a unique opportunity to collaborate in addressing unmet medical needs within niche markets, potentially increasing market share.
Financial Momentum With over 30% year-over-year profitability growth reported in 2025 and upcoming financial disclosures, Kamada demonstrates a financially healthy profile, making it an attractive partner for joint ventures or supply agreements.
Development Pipeline Kamada is actively advancing an innovative pipeline targeting unmet medical needs, offering potential collaborations for joint development, licensing, or research-focused sales opportunities.
Market Positioning As a leader in the specialty plasma-derived sector with a focus on diseases with limited treatments, Kamada provides a strategic entry point for organizations looking to expand into high-value, niche medical markets.
KAMADA uses 8 technology products and services including Open Graph, WordPress, Shopify, and more. Explore KAMADA's tech stack below.
| KAMADA Email Formats | Percentage |
| FirstL@kamada.com | 86% |
| FirstLast@kamada.com | 7% |
| First_L@kamada.com | 3% |
| FirstLa@kamada.com | 4% |
Pharmaceutical ManufacturingIsrael201-500 Employees
Kamada is a growing commercial-stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions. The company is a leader in the specialty plasma-derived field focused on diseases with limited treatment alternatives, with 6 FDA-approved products selling in over 30 countries. The company is advancing an innovative development pipeline targeting areas of significant unmet medical need.
Company Overview
Funding & FinancialsKAMADA has raised a total of $60M of funding over 6 rounds. Their latest funding round was raised on May 24, 2023 in the amount of $60M.
KAMADA's revenue is estimated to be in the range of $100M$250M
Funding & FinancialsKAMADA has raised a total of $60M of funding over 6 rounds. Their latest funding round was raised on May 24, 2023 in the amount of $60M.
KAMADA's revenue is estimated to be in the range of $100M$250M
1-888-653-2347 
support@leadiq.com